Exploration for Epilepsy

AL
AR
Overseen ByAyelet Rosenberg
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: NYU Langone Health
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand the relationship between certain brain activities and visual and physical exploration in people with epilepsy. Participants will either explore virtual environments using VR glasses or walk between rooms while researchers monitor brain signals. Suitable candidates include individuals with epilepsy who have specific brain implants and experience fewer than one debilitating seizure per week, as well as healthy individuals who can walk and wear research equipment without assistance. As an unphased trial, this study offers participants the chance to contribute to groundbreaking research in understanding epilepsy and brain function.

Do I have to stop taking my current medications for the trial?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is there any evidence suggesting that this trial's treatments are likely to be safe?

Research has shown that the treatments under study in this trial, Ambulatory Exploration and Visual Exploration, are generally safe.

For Ambulatory Exploration, studies have found that using devices to monitor seizures is usually well-tolerated. One long-term study lasting nine years showed that these brain devices reduced seizures by an average of 75%, with no major safety issues reported.

Regarding Visual Exploration, safety appears promising as well. Past research on visually sensitive seizures found that treatments involving visual tasks are safe for patients. Studies on pattern-sensitive epilepsy, a type of epilepsy triggered by visual patterns, have shown that patients handle these visual treatments well over long periods.

Overall, both treatments have been studied extensively, and the results suggest they are safe for people with epilepsy. This should provide some reassurance for those considering joining a trial testing these methods.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores innovative techniques to understand and potentially improve epilepsy management. Unlike traditional epilepsy treatments, which often rely on medications or surgeries to control seizures, this trial uses immersive virtual reality environments to study eye movements and brain activity. By analyzing how patients interact with different visual and physical spaces, the trial aims to uncover new insights into brain function and how it relates to epilepsy. These findings could open the door to more personalized and effective strategies for managing the condition.

What evidence suggests that this trial's treatments could be effective for epilepsy?

In this trial, participants will engage in various exploration tasks to manage epilepsy. Research has shown that walking around and monitoring for seizures can aid in epilepsy management. Studies have found that a portable brain wave test, known as ambulatory EEG, detects seizures 72% of the time, outperforming older methods. This improved detection helps doctors better understand and treat epilepsy.

Research has also explored the relationship between visual experiences and epilepsy. Some studies suggest that specific visual tasks can help predict seizures. These studies use advanced methods like machine learning to analyze brain activity patterns and foresee possible seizures, providing a valuable tool for managing epilepsy. Participants in this trial will engage in either ambulatory exploration or visual exploration tasks to further investigate these findings.14678

Who Is on the Research Team?

AL

Anli Liu, MD, MA

Principal Investigator

NYU Langone Health

Are You a Good Fit for This Trial?

This trial is for individuals with epilepsy who are undergoing surgical treatment or have been implanted with RNS devices. It aims to understand the brain's activity during visual and physical exploration tasks.

Inclusion Criteria

RNS patients must have an IQ greater than or equal to 80
All subjects must be able to provide informed consent
Surgical epilepsy patients must have an IQ greater than 80
See 7 more

Exclusion Criteria

All subjects must not be legally blind
I haven't had any full-body seizures in the last year.
I haven't smoked or used alcohol or drugs in the last week.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Visual Exploration in Surgical Patients

Participants will view between 10-15 panoramic environments using Meta Quest AR/VR glasses while their eye movements and head turns are tracked.

1 day
1 visit (in-person)

Ambulatory Exploration in RNS Patients and Healthy Controls

Participants will walk through and explore visually distinct rooms while wearing synchronized high-density EEG (hdEEG), eye-tracking glasses, and body position sensors.

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after exploration activities

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Ambulatory Exploration
  • Visual Exploration
Trial Overview The study examines hippocampal activity in two scenarios: when patients visually explore while monitored by iEEG during surgery, and when they move around (ambulatory exploration) with an RNS device.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Patients with RNS DevicesExperimental Treatment1 Intervention
Group II: Healthy Control ParticipantsExperimental Treatment1 Intervention
Group III: Epilepsy Surgery PatientsExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials
1,431
Recruited
838,000+

National Institute on Deafness and Other Communication Disorders (NIDCD)

Collaborator

Trials
377
Recruited
190,000+

Citations

Clinical utility of an ambulatory absence seizure detection ...Novel absence seizure detection systems have emerged in recent years, showing consistent results in ambulatory monitoring.
A retrospective review of ambulatory video-EEG reportsThis study evaluates the sensitivity and positive predictive value (PPV) of seizure diaries compared to ambulatory video-EEG reports.
Impact of ambulatory EEG in the management of patients ...In patients with confirmed epilepsy and a first normal routine EEG, ambulatory EEG showed a diagnostic yield of 86%. •. The results of ...
Ambulatory seizure forecasting with a wrist-worn device ...These results provide the first clear evidence that direct seizure forecasts are possible using wearable devices in the ambulatory setting for ...
Diagnostic Accuracy of Ambulatory EEG vs Routine EEG in ...Results. Ambulatory EEG captured IED/seizures with a sensitivity of 72%, compared with 11% for the first rEEG and 22% for the second rEEG. The ...
Safety considerations in the epilepsy monitoring unit for ...We reviewed EMU records from 116 PNES and compared them to 170 ES. Three falls (2.6%) occurred in PNES without injury compared to 6 falls (3.5%) in ES with 1 ...
Nine-year prospective efficacy and safety of brain- ...At the completion of 9 years of treatment, the median percent seizure reduction was 75%, the responder rate was 73%, and more than one-third of patients had a ≥ ...
A Digital Intervention for Capturing the Real-Time Health ...This innovative approach aims to tackle the apparently unpredictable nature of seizures by collecting real-time data on various seizure ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security